|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9246
|
|
pubmed:dateCreated |
2000-12-20
|
|
pubmed:abstractText |
The epithelial glycoprotein Ep-CAM is overexpressed in colon cancer and breast cancer. We assessed the frequency and prognostic significance of Ep-CAM in tissue specimens from 205 patients with invasive breast cancer, by immunohistochemical staining with a monoclonal antibody specific for the Ep-CAM antigen. Ep-CAM overexpression was found in 35.6% of samples and was associated with poor disease-free and overall survival.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0140-6736
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
9
|
|
pubmed:volume |
356
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1981-2
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11130529-Antigens, Neoplasm,
pubmed-meshheading:11130529-Breast Neoplasms,
pubmed-meshheading:11130529-Cell Adhesion Molecules,
pubmed-meshheading:11130529-Female,
pubmed-meshheading:11130529-Humans,
pubmed-meshheading:11130529-Immunohistochemistry,
pubmed-meshheading:11130529-Middle Aged,
pubmed-meshheading:11130529-Predictive Value of Tests,
pubmed-meshheading:11130529-Prognosis,
pubmed-meshheading:11130529-Retrospective Studies,
pubmed-meshheading:11130529-Survival Analysis
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Ep-CAM overexpression in breast cancer as a predictor of survival.
|
|
pubmed:publicationType |
Letter,
Research Support, Non-U.S. Gov't
|
